14 8月 2023 by admin in UncategorizedComments Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
24 7月 2023 by admin in UncategorizedComments Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours
11 7月 2023 by admin in UncategorizedComments Adicet Announces Appointment of Katie Peng to the Board of Directors
09 5月 2023 by admin in UncategorizedComments Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
